Jean-Paul Briand
21Patents
5h-index
27Co-inventors
69Inventor score
Filing activity: May 27, 1986 → Dec 11, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4748002A | Semi-automatic, solid-phase peptide multi-synthesizer and process for the production of synthetic peptides by the use of the multi-synthesizer | Chemistry; Metallurgy | 45 | Expired |
| US7060845B2 | Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas | Chemistry; Metallurgy | 8 | Expired |
| US7186828B2 | Cyclic urea compounds and preparation thereof | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7186739B2 | Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas | Chemistry; Metallurgy | 7 | Expired |
| US7691807B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | Chemistry; Metallurgy | 5 | Expired |
| US6455244B1 | Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5407833A | Peptides of the SM-D antigen and their use for diagnosis of systemic lupus erythematosus | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8138145B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | Chemistry; Metallurgy | 4 | Active |
| US8497349B2 | Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation | Human Necessities | 2 | Active |
| US7872098B1 | Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies | Human Necessities | 2 | Active |
| US8173767B2 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | Chemistry; Metallurgy | 1 | Active |
| US7122193B1 | Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosis | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7364744B2 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | Chemistry; Metallurgy | 1 | Expired |
| US8475800B2 | Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies | Human Necessities | 0 | Active |
| US7691899B2 | Urea oligomers, the preparation method thereof and pharmaceutical composition containing same | Chemistry; Metallurgy | 0 | Expired |
| US9243030B2 | Optically pure compounds for improved therapeutic efficiency | Human Necessities | 0 | Active |
| US9657072B2 | Modified peptides and their use for treating autoimmune diseases | Human Necessities | 0 | Active |
| US7199215B1 | Pseudopeptide, synthesis method, reagent and applications | Human Necessities | 0 | Expired |
| US9254309B2 | Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation | Human Necessities | 0 | Active |
| US10213482B2 | Methods of treating chronic inflammatory diseases | Chemistry; Metallurgy | 0 | Active |
| US8071640B2 | Urea oligomers, their preparation process and pharmaceutical compositions containing them | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.